Lv33
230 积分 2022-01-22 加入
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab
12天前
已完结
[A retrospective study of BRAF inhibitors and EGFR inhibitors combined with immune checkpoint inhibitors in patients with microsatellite stable, BRAF V600E mutated metastatic colorectal cancer]
12天前
已关闭
[Expert consensus on diagnosis and treatment of advanced non-small cell lung cancer with HER-2 alterations (2025 edition)]
12天前
已完结
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)]
12天前
已完结
[Expert consensus on clinical practice of EGFR exon20 insertion detection in non-small cell lung cancer in China (2024 edition)]
13天前
已完结
SLFN11 and ATR as targets for overcoming cisplatin resistance in ovarian cancer cells
19天前
已完结
Beyond the Guided Missile Paradigm: Embracing the Complexity of Antibody-Drug Conjugates
19天前
已完结
Long noncoding RNA ADAMTS9‐AS2 suppresses the progression of esophageal cancer by mediating CDH3 promoter methylation
22天前
已完结
Dual blockage of P-cadherin and c-Met synergistically inhibits the growth of head and neck cancer
22天前
已关闭
A First-in-Human, Phase 1, Multicenter, Open-label, Dose-Escalation Study of PCA062, an Antibody-Drug Conjugate Targeting P-Cadherin, in Patients with Solid Tumors
22天前
已完结
Virus structures and molecular biology exchange glances
2年前
已采纳
Pharmacophore modeling and its applications
3年前
已采纳
A Unified Analytical Model for Bulk and Surface Mobility in Si n- and p-Channel MOSFET's
3年前
已采纳
Characterization of gastric cancer stem-like molecular features, immune and pharmacogenomic landscapes
3年前
已采纳
Characterization of gastric cancer stem-like molecular features, immune and pharmacogenomic landscapes
3年前
已驳回
GENType: all-in-one preimplantation genetic testing by pedigree haplotyping and copy number profiling suitable for third-party reproduction
3年前
已采纳
PersonaDrive: a method for the identification and prioritization of personalized cancer drivers
3年前
已采纳
皖公网安备34019202002308
